-+ 0.00%
-+ 0.00%
-+ 0.00%
A Look At Garmin (GRMN) Valuation After Natural Cycles Integration Drives Fresh Interest
Share
Listen to the news

Garmin’s Natural Cycles integration: what it could mean for the stock

Garmin (GRMN) is drawing fresh attention after announcing a product integration with Natural Cycles, the FDA cleared birth control and fertility app, on select smartwatch models across multiple major markets.

This partnership brings overnight skin temperature tracking from compatible Garmin devices directly into the Natural Cycles app, expanding Garmin’s women’s health capabilities and potentially strengthening the appeal of its existing wearable ecosystem.

See our latest analysis for Garmin.

Garmin’s share price is at US$241.27 after a modest 1 day pullback, but a 14.5% 90 day share price return and 41.2% 1 year total shareholder return point to building momentum around its broader wearables and electronics story.

If this kind of product led growth angle interests you, it could be worth scanning the market for other hardware and platform names by checking out 34 robotics and automation stocks

With Garmin delivering a 41.2% 1 year total return and trading only about 7.9% below the consensus price target, the key question is whether the Natural Cycles story leaves more upside on the table or if the market is already paying up for future growth.

Most Popular Narrative: 7.3% Undervalued

Garmin’s most followed narrative puts fair value at $260.25, a touch above the last close of $241.27. This frames the Natural Cycles tie up as one piece of a broader premium wearables and services push.

The launch of the Garmin Connect+ premium service, which offers AI-based health and fitness insights, is likely to boost subscription-based revenue growth and improve overall margins through higher-margin services.

The new vívoactive 6 smartwatch release, with advanced features like an AMOLED display and enhanced sports apps, suggests potential revenue growth in the Fitness segment, supported by strong demand for advanced wearables.

Read the complete narrative. Read the complete narrative.

Want to see why this fair value sits above today’s price yet still assumes only moderate growth in earnings and margins? The crucial input is how much of Garmin’s future value this narrative assigns to recurring services layered on top of its hardware base, and the kind of earnings multiple it thinks that mix can support by 2028.

Result: Fair Value of $260.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, it is worth keeping in mind that higher operating expenses and softer Marine and Outdoor trends could pressure margins and test confidence in the current growth story.

Find out about the key risks to this Garmin narrative.

Another View: Market Multiple Sends a Different Signal

The narrative fair value of $260.25 suggests Garmin is 7.3% undervalued, but the current P/E of 27.9x tells a tougher story. It sits above the US Consumer Durables industry at 11.8x, peers at 18.3x, and even above the fair ratio of 21.8x, which points to valuation risk if sentiment cools.

Put simply, the share price already embeds a richer earnings tag than both sector peers and the fair ratio the market could move toward. The key question is whether Garmin can keep justifying that premium, or if expectations start to feel stretched.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:GRMN P/E Ratio as at Apr 2026
NYSE:GRMN P/E Ratio as at Apr 2026

Next Steps

There is a fair amount of optimism here, along with some clear questions, so it is worth reviewing the underlying data yourself. You can move quickly to form your own view by checking out 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If Garmin has caught your eye, do not stop here. Widen your watchlist with fresh ideas that match your goals and risk comfort using focused stock lists.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending